Rezension:

Not in at the moment http://egotastic.in.net egotasticallstars
Brean Capital analyst Gene Mack said in a note dated Sept. 5that Astex should have rejected an offer below $13 per share asit did not reflect the royalties from its drug Dacogen and itsportfolio of drugs partnered with companies including NovartisAG.

Bewertung: